| 摘要 |
<p>Subject of the present invention are assays and in vitro methods for prediction of the progression of primary chronic kidney disease (CKD) or for monitoring chronic kidney disease therapy comprising the determination of the level of ANP (A-type natriuretic peptide) and/or ADM (adrenomedullin) or its precursors or fragments thereof.</p> |
